Our case highlights SARS-CoV-2 and pembrolizumab as trigger of secondary
hemophagocytic lymphohistiocytosis. Although it is a rare complication, it must be suspected …

Hemophagocytic lymphohistiocytosis (HLH) is characterized by immune dysregulation with
extensive inflammation and tissue destruction due to abnormal immune activation. Post …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has been associated with multiple inflammatory …

Haemophagocytic lymphohistiocytosis (HLH) causing multiorgan failure has been reported
as an acute clinical presentation of COVID-19. However, the literature surrounding HLH in …

Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyper inflammatory process
caused by extensive immune activation and characterized by multi organ dysfunction …

Hemophagocytic lymphohistiocytosis (HLH) is a recognized complication of severe
coronavirus disease 2019 (COVID-19). However, this phenomenon has been reported most …

Hemophagocytic lymphohistiocytosis (HLH) is a rare, severe hyperinflammatory disease
characterized by overproduction of cytokines and hemophagocytosis of hematopoietic cells …

A previously healthy 55-year-old woman presented with fever, malaise, and a mild cough.
Chest radiograph revealed bilateral patchy infiltrates. A nasopharyngeal swab tested …

Interventions: A treatment regimen of methylprednisolone, pentaglobin, and anakinra was
developed and administered. Outcomes: One patient survived the ICU stay. Two other …

We reported a case of secondary hemophagocytic lymphohistiocytosis (HLH), a rare and life-
threatening condition, which was suspected to have been triggered by a severe case of …